Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Protalix Biotherapeutics Inc (NYSE MKT LLC:PLX)

1.17
Delayed Data
As of Mar 27
 +0.05 / +4.46%
Today’s Change
0.26
Today|||52-Week Range
1.51
+162.92%
Year-to-Date
No recent news for Protalix Biotherapeutics Inc.

Today’s Trading

Previous close1.12
Today’s open1.12
Day’s range1.11 - 1.20
Volume2,843,492
Average volume (3 months)3,554,817
Market cap$139.0M
Dividend yield--
Data as of 4:01pm ET, 03/27/2017

Growth & Valuation

Earnings growth (last year)-251.54%
Earnings growth (this year)+24.14%
Earnings growth (next 5 years)+25.00%
Revenue growth (last year)+110.79%
P/E ratioNM
Price/Sales4.90
Price/Book--

Competitors

 Today’s
change
Today’s
% change
EVGNEvogene Ltd+0.06+1.16%
PFNXPfenex Inc+0.20+3.57%
QUREUniqure NV+0.08+1.38%
NVIVInVivo Therapeutics ...+0.05+1.25%
Data as of 4:02pm ET, 03/27/2017

Financials

Last reporting dateMarch 16, 2017
EPS forecast (this quarter)-$0.11
Annual revenue (last year)$9.2M
Annual profit (last year)-$29.4M
Net profit margin-317.16%

Profile

Sector
Health Services
Industry
Services to the Health Industry
President, Chief Executive Officer &
Director
Moshe Manor
Chief Operating Officer
Tzvi Palash
Corporate headquarters
Carmiel, Haifa

Forecasts


Search for Jobs